OMX Nordic 40
2 409,66
|
2,13
|
0,09 %
|
Analysen zu OMX Nordic 40-Werten
18.09.23 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
18.09.23 | Hennes & Mauritz AB Buy | Deutsche Bank AG | |
18.09.23 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
15.09.23 | Hennes & Mauritz AB Neutral | UBS AG | |
15.09.23 | Hennes & Mauritz AB Underperform | Bernstein Research | |
15.09.23 | ABB Buy | UBS AG | |
15.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
15.09.23 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
15.09.23 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
13.09.23 | ABB Neutral | JP Morgan Chase & Co. | |
13.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
12.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
11.09.23 | AstraZeneca Overweight | Barclays Capital | |
11.09.23 | AstraZeneca Buy | UBS AG | |
11.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
08.09.23 | Novo Nordisk Overweight | Barclays Capital | |
07.09.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.09.23 | Hennes & Mauritz AB Underperform | Bernstein Research | |
06.09.23 | ABB Outperform | RBC Capital Markets | |
06.09.23 | Hennes & Mauritz AB Neutral | Goldman Sachs Group Inc. | |
05.09.23 | Novo Nordisk Sell | UBS AG | |
05.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
05.09.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.09.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.09.23 | Novo Nordisk Buy | Deutsche Bank AG | |
04.09.23 | Novo Nordisk Overweight | Barclays Capital | |
04.09.23 | ABB Market-Perform | Bernstein Research | |
30.08.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
29.08.23 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
29.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
25.08.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
24.08.23 | Hennes & Mauritz AB Underweight | JP Morgan Chase & Co. | |
21.08.23 | Novo Nordisk Overweight | Barclays Capital | |
21.08.23 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
18.08.23 | Hennes & Mauritz AB Neutral | UBS AG | |
15.08.23 | AstraZeneca Hold | Deutsche Bank AG | |
15.08.23 | Novo Nordisk Buy | Deutsche Bank AG | |
15.08.23 | AstraZeneca Neutral | Credit Suisse Group | |
14.08.23 | ABB Outperform | RBC Capital Markets | |
11.08.23 | Novo Nordisk Overweight | Barclays Capital |